NASDAQ: BLFSBiolife Solutions Revenue
Biolife Solutions revenue was $82.25M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was -$3.4M, down 111.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BLFS annual revenue was $82.3M, with 8.4% growth year-over-year.
BLFS past revenue growth
How has BLFS's revenue growth performed historically?
Company
8.44%
Industry
9.74%
Market
20.68%
BLFS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BLFS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BLFS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
BLFS revenue history
Current Revenue
$82.3M
Current Earnings
-$20.2M
Current Profit Margin
-24.5%
Be the first to know when BLFS announces revenue.
BLFS Revenue History By Year
| BLFS Yearly Revenue | BLFS Revenue | BLFS Change | BLFS Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $82.25M | $6.40M | +8.44% |
| 2023-12-31 | $75.86M | -$384.00k | -0.50% |
| 2022-12-31 | $76.24M | -$42.92M | -36.02% |
| 2021-12-31 | $119.16M | $71.07M | +147.79% |
| 2020-12-31 | $48.09M | $20.72M | +75.69% |
| 2019-12-31 | $27.37M | $7.63M | +38.64% |
| 2018-12-31 | $19.74M | $8.72M | +79.11% |
| 2017-12-31 | $11.02M | $2.80M | +33.97% |
| 2016-12-31 | $8.23M | $1.78M | +27.57% |
| 2015-12-31 | $6.45M | $258.21k | +4.17% |
| 2014-12-31 | $6.19M | -$2.76M | -30.83% |
| 2013-12-31 | $8.95M | $3.29M | +58.03% |
| 2012-12-31 | $5.66M | $2.90M | +105.28% |
| 2011-12-31 | $2.76M | $677.16k | +32.53% |
| 2010-12-31 | $2.08M | $499.97k | +31.61% |
| 2009-12-31 | $1.58M | $259.10k | +19.59% |
| 2008-12-31 | $1.32M | $350.24k | +36.02% |
| 2007-12-31 | $972.26k | $369.04k | +61.18% |
| 2006-12-31 | $603.22k | -$11.50k | -1.87% |
| 2005-12-31 | $614.72k | -$11.99k | -1.91% |
| 2004-12-31 | $626.71k | $21.20k | +3.50% |
| 2003-12-31 | $605.51k | -$243.28k | -28.66% |
| 2002-12-31 | $848.79k | $426.52k | +101.01% |
| 2001-12-31 | $422.27k | -$767.23k | -64.50% |
| 2000-12-31 | $1.19M | -$587.05k | -33.04% |
| 1999-12-26 | $1.78M | -$593.20k | -25.03% |
| 1998-12-27 | $2.37M | -$1.20M | -33.65% |
| 1997-12-28 | $3.57M | -$3.27M | -47.82% |
| 1996-06-30 | $6.84M | -$6.75M | -49.66% |
| 1995-06-30 | $13.59M | $155.69k | +1.16% |
| 1994-06-30 | $13.44M | N/A | N/A |
Biolife Solutions Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.